Conestoga Capital Advisors, LLC Johnson & Johnson Transaction History

Conestoga Capital Advisors, LLC

$7.22 Billion
Q3 2024

A detailed history of Conestoga Capital Advisors, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Conestoga Capital Advisors, LLC holds 2,025 shares of JNJ stock, worth $295,346. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,025

Previous 2,460 17.68%

Holding current value

$295,346

Previous $359,000 8.64%

% of portfolio

0.0%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$145.48 - $167.38 $63,283 - $72,810	-435 Reduced 17.68%	2,025 $328,000
Q2 2024 Jul 26, 2024	SELL	$144.38 - $157.78 $54,864 - $59,956	-380 Reduced 13.38%	2,460 $359,000
Q1 2024 Apr 26, 2024	SELL	$155.22 - $162.74 $54,327 - $56,959	-350 Reduced 10.97%	2,840 $449,000
Q4 2023 Jan 26, 2024	BUY	$145.6 - $158.88 $10,192 - $11,121	70 Added 2.24%	3,190 $500,000
Q3 2023 Oct 27, 2023	SELL	$155.75 - $174.48 $32,707 - $36,640	-210 Reduced 6.31%	3,120 $485,000
Q2 2023 Jul 28, 2023	SELL	$154.35 - $166.11 $54,022 - $58,138	-350 Reduced 9.51%	3,330 $551,000
Q1 2023 Apr 21, 2023	SELL	$151.05 - $180.26 $7,552 - $9,013	-50 Reduced 1.34%	3,680 $570,000
Q4 2022 Jan 31, 2023	BUY	$160.2 - $179.79 $15,218 - $17,080	95 Added 2.61%	3,730 $658,000
Q1 2022 Apr 25, 2022	BUY	$158.14 - $179.59 $22,139 - $25,142	140 Added 4.01%	3,635 $644,000
Q4 2021 Jan 21, 2022	BUY	$155.93 - $173.01 $2,338 - $2,595	15 Added 0.43%	3,495 $598,000
Q3 2021 Oct 22, 2021	BUY	$161.5 - $179.47 $6,460 - $7,178	40 Added 1.16%	3,480 $562,000
Q1 2021 Apr 23, 2021	SELL	$153.07 - $170.48 $59,085 - $65,805	-386 Reduced 10.09%	3,440 $565,000
Q4 2020 Jan 26, 2021	SELL	$137.11 - $157.38 $23,308 - $26,754	-170 Reduced 4.25%	3,826 $602,000
Q2 2020 Aug 03, 2020	BUY	$128.81 - $155.51 $100,471 - $121,297	780 Added 24.25%	3,996 $562,000
Q1 2020 Apr 17, 2020	SELL	$111.14 - $153.99 $5,001 - $6,929	-45 Reduced 1.38%	3,216 $422,000
Q4 2019 Jan 24, 2020	SELL	$127.5 - $146.44 $53,550 - $61,504	-420 Reduced 11.41%	3,261 $476,000
Q3 2019 Oct 25, 2019	SELL	$126.95 - $142.14 $12,695 - $14,213	-100 Reduced 2.64%	3,681 $476,000
Q4 2018 Jan 28, 2019	SELL	$122.84 - $147.84 $13,512 - $16,262	-110 Reduced 2.83%	3,781 $488,000
Q3 2017 Oct 20, 2017	BUY	$129.47 - $135.38 $503,767 - $526,763	3,891	3,891 $506,000

Others Institutions Holding JNJ

# of Institutions

4,275

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $381B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Conestoga Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Conestoga Capital Advisors, LLC with notifications on news.

Account

Conestoga Capital Advisors, LLC Johnson & Johnson Transaction History